IBDEI10R ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17947,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,17948,0)
 ;;=V66.7^^94^1138^8
 ;;^UTILITY(U,$J,358.3,17948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17948,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,17948,1,5,0)
 ;;=5^Encounter for Palliative Care
 ;;^UTILITY(U,$J,358.3,17948,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,17949,0)
 ;;=V11.4^^94^1138^20
 ;;^UTILITY(U,$J,358.3,17949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17949,1,2,0)
 ;;=2^V11.4
 ;;^UTILITY(U,$J,358.3,17949,1,5,0)
 ;;=5^Hx Combat/Operational Stress
 ;;^UTILITY(U,$J,358.3,17949,2)
 ;;=^339674
 ;;^UTILITY(U,$J,358.3,17950,0)
 ;;=V60.1^^94^1138^22
 ;;^UTILITY(U,$J,358.3,17950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17950,1,2,0)
 ;;=2^V60.1
 ;;^UTILITY(U,$J,358.3,17950,1,5,0)
 ;;=5^Inadequate Housing
 ;;^UTILITY(U,$J,358.3,17950,2)
 ;;=^295540
 ;;^UTILITY(U,$J,358.3,17951,0)
 ;;=V62.84^^94^1138^49
 ;;^UTILITY(U,$J,358.3,17951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17951,1,2,0)
 ;;=2^V62.84
 ;;^UTILITY(U,$J,358.3,17951,1,5,0)
 ;;=5^Suicidal Ideation
 ;;^UTILITY(U,$J,358.3,17951,2)
 ;;=^332876
 ;;^UTILITY(U,$J,358.3,17952,0)
 ;;=V62.85^^94^1138^18
 ;;^UTILITY(U,$J,358.3,17952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17952,1,2,0)
 ;;=2^V62.85
 ;;^UTILITY(U,$J,358.3,17952,1,5,0)
 ;;=5^Homicidal Ideation
 ;;^UTILITY(U,$J,358.3,17952,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,17953,0)
 ;;=V58.61^^94^1138^25
 ;;^UTILITY(U,$J,358.3,17953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17953,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,17953,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,17953,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,17954,0)
 ;;=V58.62^^94^1138^24
 ;;^UTILITY(U,$J,358.3,17954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17954,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,17954,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,17954,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,17955,0)
 ;;=V58.63^^94^1138^26
 ;;^UTILITY(U,$J,358.3,17955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17955,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,17955,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,17955,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,17956,0)
 ;;=V58.64^^94^1138^30
 ;;^UTILITY(U,$J,358.3,17956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17956,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,17956,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,17956,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,17957,0)
 ;;=V58.65^^94^1138^32
 ;;^UTILITY(U,$J,358.3,17957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17957,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,17957,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,17957,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,17958,0)
 ;;=V58.66^^94^1138^27
 ;;^UTILITY(U,$J,358.3,17958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17958,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,17958,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,17958,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,17959,0)
 ;;=V58.67^^94^1138^29
 ;;^UTILITY(U,$J,358.3,17959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17959,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,17959,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,17959,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,17960,0)
 ;;=V58.68^^94^1138^28
 ;;^UTILITY(U,$J,358.3,17960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17960,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,17960,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,17960,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,17961,0)
 ;;=V58.69^^94^1138^31
 ;;
 ;;$END ROU IBDEI10R
